Gubra A/S (CPH:GUBRA)
Denmark · Delayed Price · Currency is DKK 376.00
-16.60 (-4.23%)
Feb 13, 2026, 12:59 PM CET
Gubra Employees
Gubra had 275 employees as of June 30, 2025. The number of employees increased by 15 or 5.77% since the number was reported on December 31, 2024.
Employees
275
Change
15
Growth
5.77%
Revenue / Employee
9.59M DKK
Profits / Employee
6.35M DKK
Market Cap
6.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 275 | 15 | 5.77% |
| Dec 31, 2024 | 260 | 40 | 18.18% |
| Dec 31, 2023 | 220 | 26 | 13.40% |
| Dec 31, 2022 | 194 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Coloplast | 16,744 |
| GN Store Nord | 7,371 |
| Ambu A/S | 5,200 |
| H. Lundbeck | 5,039 |
| Embla Medical | 4,195 |
| ALK-Abelló | 2,764 |
| Genmab | 2,681 |
Gubra News
- 9 months ago - Gubra’s Innovation in Peptide-Based Drug Discovery - Nasdaq
- 1 year ago - Healthy Returns: AbbVie is the newest potential weight loss drug market player - CNBC
- 1 year ago - AbbVie Steps Into The Ring In The Obesity Drug Wars - Seeking Alpha
- 1 year ago - AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race - Benzinga
- 1 year ago - AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal - Investopedia
- 1 year ago - AbbVie (ABBV) Enters Weight Loss Market with $2.2 Billion Gubra Deal - GuruFocus
- 1 year ago - AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. - Investor's Business Daily
- 1 year ago - AbbVie forays into obesity market with up to $2.2B Gubra license deal - Seeking Alpha